US 11725005
Compositions and methods for inhibiting kinases
granted A61KA61K2300/00A61K31/506
Quick answer
US patent 11725005 (Compositions and methods for inhibiting kinases) held by Inhibikase Therapeutics, Inc. expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibikase Therapeutics, Inc.
- Grant date
- Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K2300/00, A61K31/506, A61K45/06, A61P